The Increasing Medication Access for Seniors Act of 2025 proposes interest-free monthly payments for costly Medicare prescriptions, improving affordability and transparency in the Medicare Prescription Payment Plan.
Medicare open enrollment runs through Dec. 7, 2025. Learn about key 2026 changes in Medicare Advantage and Part D plans, prescription drug costs, premium adjustments, and cost-saving programs.
The New Democrat Coalition released a Health Care Action Plan targeting healthcare affordability, access expansions, and protections for Medicaid and Medicare, proposing over 45 actionable policy reforms. The plan addresses cost reduction, rural healthcare support, behavioral health, women's health services, and counters health misinformation.
Medicare Advantage plans in Rochester-Finger Lakes are terminating in 2026, requiring beneficiaries to select new plans by Dec 7 or revert to Original Medicare with higher costs. Understand the implications for prescription costs and coverage changes.
Medicare Part D faces significant plan reductions and rising costs in 2026. Beneficiaries must review their drug plans before the December 7 deadline to avoid premium hikes and coverage losses.
CMS expands Medicare drug price negotiations to 15 more medications starting in 2027, including popular diabetes and weight loss treatments, aiming to reduce prescription costs and save Medicare billions.
Medicare Part B premiums are set to rise significantly in 2026 amid medical inflation, while Part D prescription drug costs slightly decline nationally. Enrollment opens October 15 for plan changes including Medicare Advantage and Medigap options.
Senator Peter Welch calls for bipartisan cooperation to extend ACA tax credits and prevent a government shutdown that threatens affordable healthcare for millions.
FDA approves prescription leucovorin for autism treatment; HHS addresses investment and regulatory concerns involving CMS administrator Dr. Mehmet Oz amid public discourse.
Rising healthcare inflation is leading to the largest health coverage cost increase for U.S. employers since 2010, driven by higher medical care prices and prescription drug expenses, especially GLP-1 drugs.
